Whittier Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75M Sell
39,331
-288,895
-88% -$15.7M 0.02% 315
2026
Q1
$20.5M Buy
328,226
+322,161
+5,312% +$25.8M 0.23% 87
2025
Q4
$593K Sell
6,065
-92
-1% -$9.02K 0.01% 420
2025
Q3
$599K Buy
6,157
+61
+1% +$6.32K 0.01% 414
2025
Q2
$655K Hold
6,096
0.01% 455
2025
Q1
$615K Sell
6,096
-5
-0.1% -$503 0.01% 452
2024
Q4
$545K Buy
6,101
+257
+4% +$22.6K 0.01% 476
2024
Q3
$490K Sell
5,844
-246
-4% -$19.4K 0.01% 510
2024
Q2
$469K Buy
6,090
+397
+7% +$29.1K 0.01% 495
2024
Q1
$390K Hold
5,693
0.01% 530
2023
Q4
$329K Buy
5,693
+117
+2% +$6.25K 0.01% 558
2023
Q3
$294K Sell
5,576
-67
-1% -$3.51K 0.01% 562
2023
Q2
$305K Sell
5,643
-1,222
-18% -$63.8K 0.01% 555
2023
Q1
$343K Buy
6,865
+2,823
+70% +$133K 0.01% 542
2022
Q4
$187K Sell
4,042
-43
-1% -$1.86K ﹤0.01% 664
2022
Q3
$158K Buy
4,085
+1,799
+79% +$72.2K ﹤0.01% 686
2022
Q2
$85K Buy
2,286
+527
+30% +$21.5K ﹤0.01% 832
2022
Q1
$78K Buy
1,759
+43
+3% +$1.86K ﹤0.01% 885
2021
Q4
$73K Hold
1,716
﹤0.01% 894
2021
Q3
$74K Hold
1,716
﹤0.01% 843
2021
Q2
$73K Hold
1,716
﹤0.01% 860
2021
Q1
$66K Sell
1,716
-1,574
-48% -$59.6K ﹤0.01% 865
2020
Q4
$118K Buy
3,290
+1,567
+91% +$56.5K ﹤0.01% 679
2020
Q3
$66K Buy
1,723
+174
+11% +$6.71K ﹤0.01% 775
2020
Q2
$54K Sell
1,549
-765
-33% -$27.6K ﹤0.01% 783
2020
Q1
$76K Buy
2,314
+94
+4% +$3.67K ﹤0.01% 715
2019
Q4
$100K Buy
2,220
+882
+66% +$36.9K ﹤0.01% 697
2019
Q3
$54K Buy
1,338
+269
+25% +$11.4K ﹤0.01% 816
2019
Q2
$46K Buy
1,069
+256
+31% +$9.85K ﹤0.01% 813
2019
Q1
$31K Sell
813
-403
-33% -$15.4K ﹤0.01% 871
2018
Q4
$43K Buy
1,216
+403
+50% +$14.6K ﹤0.01% 805
2018
Q3
$31K Hold
813
﹤0.01% 872
2018
Q2
$27K Hold
813
﹤0.01% 867
2018
Q1
$22K Hold
813
﹤0.01% 916
2017
Q4
$20K Buy
813
+748
+1,151% +$20.6K ﹤0.01% 918
2017
Q3
$2K Hold
65
﹤0.01% 1230
2017
Q2
$2K Hold
65
﹤0.01% 1155
2017
Q1
$2K Hold
65
﹤0.01% 1253
2016
Q4
$1K Hold
65
﹤0.01% 1142
2016
Q3
$2K Hold
65
﹤0.01% 1109
2016
Q2
$2K Hold
65
﹤0.01% 1127
2016
Q1
$1K Hold
65
﹤0.01% 1139
2015
Q4
$1K Hold
65
﹤0.01% 1148
2015
Q3
$1K Hold
65
﹤0.01% 1122
2015
Q2
$1K Sell
65
-603
-90% -$10.8K ﹤0.01% 1169
2015
Q1
$12K Buy
668
+603
+928% +$9.53K ﹤0.01% 982
2014
Q4
$1K Hold
65
﹤0.01% 1040
2014
Q3
$1K Hold
65
﹤0.01% 1018
2014
Q2
$1K Hold
65
﹤0.01% 1016
2014
Q1
$1K Hold
65
﹤0.01% 1043
2013
Q4
$1K Hold
65
﹤0.01% 1044
2013
Q3
$1K Hold
65
﹤0.01% 1040
2013
Q2
$1K Buy
+65
New +$551 ﹤0.01% 1042

Other funds holding BSX

Whittier Trust's BSX Position: Q2 2026 in Review

Whittier Trust reduced its Boston Scientific (BSX) stake by 88% in Q2 2026, selling an estimated $15.7M and leaving 39,331 shares worth $1.75M. The position accounts for 0.02% of the portfolio, ranked #315.

Whittier Trust first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $20.5M in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Whittier Trust held 39,331 shares of Boston Scientific worth $1.75M as of Q2 2026.
  • Whittier Trust sold 288,895 Boston Scientific shares in Q2 2026, an estimated $15.7M.
  • Boston Scientific made up 0.02% of Whittier Trust's portfolio in Q2 2026, its #315 holding.
  • Whittier Trust first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • Whittier Trust's Boston Scientific position peaked at $20.5M in Q1 2026.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.